nach oben

Current Psychiatry Reports

Erschienen in:

01.01.2019 | Public Policy and Public Health (G Norquist, Section Editor)

Global Burden of Disease and the Impact of Mental and Addictive Disorders

verfasst von: Jürgen Rehm, Kevin D. Shield

Erschienen in: Current Psychiatry Reports | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

This contribution reviews the newest empirical evidence regarding the burden of mental and addictive disorders and weighs their importance for global health in the first decades of the twenty-first century.

Recent Findings

Mental and addictive disorders affected more than 1 billion people globally in 2016. They caused 7% of all global burden of disease as measured in DALYs and 19% of all years lived with disability. Depression was associated with most DALYs for both sexes, with higher rates in women as all other internalizing disorders, whereas other disorders such as substance use disorders had higher rates in men.

Summary

Mental and addictive disorders affect a significant portion of the global population with high burden, in particular in high- and upper-middle-income countries. The relative share of these disorders has increased in the past decades, in part due to stigma and lack of treatment. Future research needs to better analyze the role of mental and addictive disorders in shifts of life expectancy.

World Health Organization. NCD Global Monitoring Framework: ensuring progress on noncommunicable diseases in countries 2017 Accessed: 10/30/2018. Available from: http://www.who.int/nmh/global_monitoring_framework/en/.

United Nations. Sustainable Development Goals: 17 goals to transform our world. 2017 Accessed: 10/30/2018. Available from: http://www.un.org/sustainabledevelopment/sustainable-development-goals/.

•• Omran AR. The epidemiologic transition. A theory of the epidemiology of population change. Milbank Mem Fund Q. 1971;49:509–38 The classic paper on epidemiologic transition, which summarized all major changes related to increasing health. CrossRef

GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1084–150.CrossRef

GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–210.CrossRef

Miranda JJ, Kinra S, Casas JP, Davey Smith G, Ebrahim S. Non-communicable diseases in low- and middle-income countries: context, determinants and health policy. Tropical Med Int Health. 2008;13(10):1225–34.CrossRef

• Ezzati M, Pearson-Stuttard J, Bennett JE, Mathers CD. Acting on non-communicable diseases in low- and middle-income tropical countries. Nature. 2018;559(7715):507–16 Important overview on development of NCD in low- and middle-income countries. CrossRef

McKeown RE. The epidemiologic transition: changing patterns of mortality and population dynamics. Am J Lifestyle Med. 2009;3(Suppl 1):19S–26S.CrossRef

Riley JC. Rising life expectancy: a global history. Cambridge: Cambridge University Press; 2001.CrossRef

10.

• Deaton A. The Great Escape – health, wealth and the origins of inequality. Princeton: Princeton University Press; 2013. Analyses of historical developments and the links between economic wealth and health.

11.

World Health Organization. Global action plan for the prevention and control of noncommunicable diseases 2013–2020. 2013 Accessed: 10/30/2018. Available from: http://apps.who.int/iris/bitstream/10665/94384/1/9789241506236_eng.pdf.

12.

Bennett JE, Stevens GA, Mathers CD, Bonita R, Rehm J, Kruk ME, et al. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet. 2018;392(10152):1072–88.CrossRef

13.

Lopez AD, Williams TN, Levin A, Tonelli M, Singh JA, Burney PG, et al. Remembering the forgotten non-communicable diseases. BMC Med. 2014;12(1):200.CrossRef

14.

Rehm J, Probst C. Decreases of life expectancy despite decreases in non-communicable disease mortality: the role of substance use and socioeconomic status. Eur Addict Res. 2018;24(2):53–9.CrossRef

15.

Lloyd-Sherlock P, Ebrahim S, McKee M, Prince M. A premature mortality target for the SDG for health is ageist. Lancet. 2015;385(9983):2147–8.CrossRef

16.

Shield KD, Rehm J. Substance use and the objectives of current global health frameworks: measurement matters. Addiction. 2018. https://doi.org/10.1111/add.14485.

17.

Murray CJL. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ. 1994;72(3):429–45.PubMedPubMedCentral

18.

Beltrán-Sánchez H, Soneji S, Crimmins EM. Past, present, and future of healthy life expectancy. Cold Spring Harb Perspect Med. 2015;5(11). https://doi.org/10.1101/cshperspect.a025957

19.

• United Nations University, United Nations, World Bank Group, The University of Tokyo. Mental health, well-being and disability: a new global priority key United Nations resolutions and documents 2015 Accessed: 10/30/2018. Available from: http://pubdocs.worldbank.org/en/619761454942779225/Mental-Health-Well-being-Disability-A-New-Global-Priority.pdf. Important document on the role of mental health in the Substainable Development Framework.

20.

•• United Nations. Sustainable Development Goal 3: ensure healthy lives and promote well-being for all at all ages. 2016 Accessed: 10/30/2018. Available from: https://sustainabledevelopment.un.org/sdg3. Most important basis of current health policy.

21.

Ferrari AJ, Norman RE, Freedman G, Baxter AJ, Pirkis JE, Harris MG, et al. The burden attributable to mental and substance use disorders as risk factors for suicide: findings from the Global Burden of Disease Study 2010. PLoS One. 2014;9(4):e91936.CrossRef

22.

Charlson FJ, Baxter AJ, Dua T, Degenhardt L, Whiteford HA, Vos T. Excess mortality from mental, neurological, and substance use disorders in the Global Burden of Disease Study 2010. In: Patel V, Dua T, Laxminarayan R, Medina-Mora ME, editors. Mental, neurological, and substance use disorders, disease control priorities 4. Washington, DC: The International Bank for Reconstruction and Development/The World Bank; 2016. p. 41–65.

23.

Tannenbaum C, Lexchin J, Tamblyn R, Romans S. Indicators for measuring mental health: towards better surveillance. Healthc Policy = Politiques de sante. 2009;5(2):e177–86.CrossRef

24.

Murray CJL, Salomon J, Mathers C, Lopez A. Summary measures of population health: concepts, ethics, measurement and applications. Geneva: WHO; 2002.

25.

GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59.CrossRef

26.

GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1260–344.CrossRef

27.

• Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382(9904):1575–86 Last epidemiological overview of global burden of mental and addictive disorders. CrossRef

28.

Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2016 (GBD 2016) results. 2017 Accessed: 10/30/2018. Available from: http://ghdx.healthdata.org/gbd-results-tool.

29.

Global Burden of Disease Study 2015. Global Burden of Disease Study 2015 (GBD 2015) causes of death and nonfatal causes mapped to ICD codes. 2016 Accessed: 10/30/2018. Available from: http://ghdx.healthdata.org/record/global-burden-disease-study-2015-gbd-2015-causes-death-and-nonfatal-causes-mapped-icd-codes.

30.

Krueger RF. The structure of common mental disorders. Arch Gen Psychiatry. 1999;56(10):921–6.CrossRef

31.

Baxter AJ, Scott KM, Ferrari AJ, Norman RE, Vos T, Whiteford HA. Challenging the myth of an “epidemic” of common mental disorders: trends in the global prevalence of anxiety and depression between 1990 and 2010. Depress Anxiety. 2014;31(6):506–16.CrossRef

32.

Rehm J, Dawson D, Frick U, Gmel G, Roerecke M, Shield KD, et al. Burden of disease associated with alcohol use disorders in the United States. Alcohol Clin Exp Res. 2014;38(4):1068–77.CrossRef

33.

World Health Organization. Disease burden and mortality estimates: cause-specific mortality, 2000-2016. 2018 Accesssed: 10/30/2018. Available from: https://stats.oecd.org/glossary/detail.asp?ID=6325. Accessed 20 Jan 2019.

34.

Organization for Economic Co-operation and Development OECD. Glossary of statistical terms: underlying cause of death. 2018.

35.

Harris EC, Barraclough B. Excess mortality of mental disorder. Br J Psychiatry. 1998;173:11–53.CrossRef

36.

Roerecke M, Rehm J. Cause-specific mortality risk in alcohol use disorder treatment patients: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(3):906–19.CrossRef

37.

World Health Organization. International statistical classification of diseases and related health problems 10th Revision 2016 Accessed: 10/30/2018. Available from: http://apps.who.int/classifications/icd10/browse/2016/en.

38.

Lajoie J. Understanding the measurement of Global Burden of Disease 2015 Accessed: 10/30/2018. Available from: https://nccid.ca/publications/understanding-the-measurement-of-global-burden-of-disease/.

39.

The World Bank. GDP per capita, PPP (current international $) 2018 [Accessed: 10/30/2018]. Available from: https://data.worldbank.org/indicator/NY.GDP.PCAP.PP.CD?end=2017&start=2017&view=bar&year_high_desc=true

40.

Steel Z, Marnane C, Iranpour C, Chey T, Jackson JW, Patel V, et al. The global prevalence of common mental disorders: a systematic review and meta-analysis 1980-2013. Int J Epidemiol. 2014;43(2):476–93.CrossRef

41.

The World Bank. GINI Index (World Bank estimate) 2018 [Accessed: 10/30/2018]. Available from: https://data.worldbank.org/indicator/SI.POV.GINI.

42.

Carter KN, Blakely T, Collings S, Imlach Gunasekara F, Richardson K. What is the association between wealth and mental health? J Epidemiol Community Health. 2009;63(3):221–6.CrossRef

43.

Lund C, Breen A, Flisher AJ, Kakuma R, Corrigall J, Joska JA, et al. Poverty and common mental disorders in low and middle income countries: a systematic review. Soc Sci Med. 2010;71(3):517–28.CrossRef

44.

• Saxena S, Thornicroft G, Knapp M, Whiteford H. Resources for mental health: scarcity, inequity, and inefficiency. Lancet. 2007;370(9590):878–89 Important call for action on increasing resources for mental health. CrossRef

45.

World Health Organization. WHO Mental Health Gap Action Programme (mhGAP) 2018 Accessed: 10/30/2018. Available from: https://www.who.int/mental_health/mhgap/en/.

46.

• Patel V, Saxena S, Lund C, Thornicroft G, Baingana F, Bolton P, et al. The Lancet Commission on global mental health and sustainable development. Lancet. 2018;392(10157):1553–1598. https://doi.org/10.1016/S0140-6736(18)31612-X. First results of the Lancet Commission pointing to the need to increase resources for mental health in order to achieve sustainable development.

47.

Patel V, Saxena S, Frankish H, Boyce N. Sustainable development and global mental health--a Lancet Commission. Lancet. 2016;387(10024):1143–5.CrossRef

48.

Milanovic B. Global inequality: a new approach for the age of globalization. Boston: The Belknap Press of Harvard University Press; 2016.CrossRef

49.

• Case A, Deaton A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci U S A. 2015;112(49):15078–83 Influential paper on the importance of deaths of despair for lift expectancy in large parts of the US general population. CrossRef

50.

Chetty R, Stepner M, Abraham S, Lin S, Scuderi B, Turner N, et al. The association between income and life expectancy in the United States, 2001-2014. JAMA. 2016;315(16):1750–66.CrossRef

51.

Singh GK, Siahpush M. Widening rural–urban disparities in all-cause mortality and mortality from major causes of death in the USA, 1969–2009. J Urban Health. 2014;91(2):272–92.CrossRef

52.

Case A, Deaton A. Mortality and morbidity in the 21(st) century. Brook Pap Econ Act. 2017;2017:397–476.CrossRef

53.

Yoon YH, Chen CM, Yi HY. Unintentional alcohol and drug poisoning in association with substance use disorders and mood and anxiety disorders: results from the 2010 Nationwide Inpatient Sample. Inj Prev. 2014;20(1):21–8.CrossRef

54.

Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, et al. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev. 2010;29(4):437–45.CrossRef

55.

Schwarzinger M, Baillot S, Yazdanpanah Y, Rehm J, Mallet V. Alcohol use disorders and the burden of chronic hepatitis C in France, 2008-2013: a nationwide retrospective cohort study. J Hepatol. 2017;67(3):454–61.CrossRef

56.

Imtiaz S, Probst C, Rehm J. Substance use and population life expectancy in the USA: interactions with health inequalities and implications for policy. Drug Alcohol Rev. 2018;37:S263–S7.CrossRef

57.

Probst C, Rehm J. Alcohol use, opioid overdose and socioeconomic status in Canada: a threat to life expectancy? Can Med Assoc J. 2018;190(44):E1294–5.CrossRef

58.

• Rehm J, Anderson P, Fischer B, Gual A, Room R. Policy implications of marked reversals of population life expectancy caused by substance use. BMC Med. 2016;14:42 One of the first papers to point to the role of addictive disorders in changing the course of life expectancy. CrossRef

59.

Robine J-M. Summarizing health status. In: Pencheon D, Guest C, Melzer D, Gray JAM, editors. Oxford handbook of public health practice. 2nd ed. Oxford: Oxford University Press; 2006. p. 160–8.

60.

Pathare S, Brazinova A, Levav I. Care gap: a comprehensive measure to quantify unmet needs in mental health. Epidemiol Psychiatr Sci. 2018;27(5):463–7.CrossRef

Titel: Global Burden of Disease and the Impact of Mental and Addictive Disorders
verfasst von: Jürgen Rehm
Kevin D. Shield
Publikationsdatum: 01.01.2019
Verlag: Springer US
Erschienen in: Current Psychiatry Reports / Ausgabe 2/2019
Print ISSN: 1523-3812
Elektronische ISSN: 1535-1645
DOI: https://doi.org/10.1007/s11920-019-0997-0

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Global Burden of Disease and the Impact of Mental and Addictive Disorders

Abstract

Purpose of Review

Recent Findings

Summary

Neu im Fachgebiet Psychiatrie

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Klinikreform soll zehntausende Menschenleben retten

Update Psychiatrie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Purpose of Review

Recent Findings

Summary

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Intimate Partner Homicide Suicide: a Mini-Review of the Literature (2012–2018)

Identification and Management of Domestic and Sexual Violence in Primary Care in the #MeToo Era: an Update

Treatments of Posttraumatic Stress Disorder in Civilian Populations

Parenting in Patients with Borderline Personality Disorder, Sequelae for the Offspring and Approaches to Treatment and Prevention

Does Prenatal Maternal Distress Contribute to Sex Differences in Child Psychopathology?

Links Between Stress, Sleep, and Inflammation: Are there Sex Differences?

Neu im Fachgebiet Psychiatrie

So wirken verschiedene Alkoholika auf den Blutdruck

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

ADHS-Medikation erhöht das kardiovaskuläre Risiko

Klinikreform soll zehntausende Menschenleben retten

Update Psychiatrie